AAAAAA
Results:
1-7
|
Results: 7
Authors:
Gogelein, H
Ruetten, H
Albus, U
Englert, HC
Busch, AE
Citation: H. Gogelein et al., Effects of the cardioselective K-ATP channel blocker HMR 1098 on cardiac function in isolated perfused working rat hearts and in anesthetized rats during ischemia and reperfusion, N-S ARCH PH, 364(1), 2001, pp. 33-41
Authors:
Englert, HC
Gerlach, U
Goegelein, H
Hartung, J
Heitsch, H
Mania, D
Scheidler, S
Citation: Hc. Englert et al., Cardioselective K-ATP channel blockers derived from a new series of m-anisamidoethylbenzenesulfonylthioureas, J MED CHEM, 44(7), 2001, pp. 1085-1098
Authors:
Jung, O
Englert, HC
Jung, W
Gogelein, H
Scholkens, BA
Busch, AE
Linz, W
Citation: O. Jung et al., The K-ATP channel blocker HMR 1883 does not abolish the benefit of ischemic preconditioning on myocardial infarct mass in anesthetized rabbits, N-S ARCH PH, 361(4), 2000, pp. 445-451
Authors:
Wirth, KJ
Uhde, J
Rosenstein, B
Englert, HC
Gogelein, H
Scholkens, BA
Busch, AE
Citation: Kj. Wirth et al., K-ATP channel blocker HMR 1883 reduces monophasic action potential shortening during coronary ischemia in anesthetised pigs, N-S ARCH PH, 361(2), 2000, pp. 155-160
Authors:
Gogelein, H
Hartung, J
Englert, HC
Citation: H. Gogelein et al., Molecular basis, pharmacology and physiological role of cardiac K-ATP channels, CELL PHYS B, 9(4-5), 1999, pp. 227-241
Authors:
Wirth, KJ
Klaus, E
Englert, HC
Scholkens, BA
Linz, W
Citation: Kj. Wirth et al., HMR 1883, a cardioselective K-ATP channel blocker, inhibits ischaemia- andreperfusion-induced ventricular fibrillation in rats, N-S ARCH PH, 360(3), 1999, pp. 295-300
Authors:
Wirth, KJ
Rosenstein, B
Uhde, J
Englert, HC
Busch, AE
Scholkens, BA
Citation: Kj. Wirth et al., ATP-sensitive potassium channel blocker HMR 1883 reduces mortality and ischemia-associated electrocardiographic changes in pigs with coronary occlusion, J PHARM EXP, 291(2), 1999, pp. 474-481
Risultati:
1-7
|